July 2026 GLP-1 Price Index: Every Major Provider's Current Monthly Cost

What does GLP-1 medication actually cost in July 2026? We tracked pricing across every major telehealth provider to build the most comprehensive price index available. No guesswork, no outdated data — just verified numbers you can use to make an informed decision.

The short version: compounded semaglutide ranges from $99 to $300+ per month depending on your provider, dose, and subscription commitment. Compounded tirzepatide starts around $133 and can exceed $350. The spread is enormous — and that's exactly why this index exists.

Compounded Semaglutide: Monthly Cost by Provider

The following prices represent the lowest published monthly rate for compounded injectable semaglutide at each provider. Actual costs may vary based on dose level, subscription length, and individual treatment plans.

Compounded Tirzepatide: Monthly Cost by Provider

Tirzepatide is the dual-action GLP-1/GIP agonist (brand names: Mounjaro, Zepbound). Compounded versions are generally more expensive than compounded semaglutide.

Brand-Name Pricing Reference

For context, here's what the FDA-approved brand-name versions cost without insurance:

What the Data Tells Us

The price gap between the cheapest and most expensive compounded semaglutide options is roughly 3x ($99 vs $297+). For tirzepatide, it's about 2.5x ($133 vs $299+). These aren't small differences — over 12 months, choosing a lower-cost provider could save you $1,200 to $2,400.

But price isn't the only factor. Some providers include comprehensive clinical monitoring, lab work, and nutritional coaching in their fees. Others offer bare-bones medication access. The cheapest option isn't always the best value — but the most expensive option isn't always the most comprehensive either.

Use this index as your starting point, then verify current pricing directly with any provider you're considering. Prices change frequently in this market.